Lyell Immunopharma Other Long Term Liabilities (Quarterly) Trends

Lyell Immunopharma, Inc. (LYEL)

23.83 +0.12 (+0.51%) USD | NASDAQ | Jan 14, 15:54

View Other Long Term Liabilities (Quarterly) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Nektar Therapeutics	Upgrade
GT Biopharma, Inc.	--
Ionis Pharmaceuticals, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade